Figure 2 Preclinical Results: Quantification of GSH, MDA, IL-6, TNF-, and IFN- Levels in Healthy Compared to T2DM Subjects For confirmation and demonstration of previous study findings, the levels of the reduced form of GSH, MDA, IL-6, TNF-, and IFN- were compared in healthy and T2DM groups and were measured in the plasma and RBCs isolated from peripheral blood of healthy and T2DM subjects
The peptide has been studied for potential applications in chronic wound management studies, skin graft survival enhancement, and post-operative incision healing optimization
10.2174/13816128113199990421 62 SeiwerthS.MilavicM.VukojevicJ.GojkovicS.KrezicI.VuleticL
89 In conclusion, BPC-157 offers a compelling case study in modern biomedical science: a promising therapy with loads of preclinical support and an eager fan base, standing on the threshold of mainstream acceptance but held back by unanswered questions